Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26.590
Filter
1.
Ghana Med J ; 58(1): 26-33, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38957281

ABSTRACT

Objectives: Patients requiring surgery for secondary peritonitis demonstrate a significantly increased risk for incisional surgical site infection. This study aimed to evaluate the efficacy of subcutaneous wound drain post-laparotomy for contaminated surgical wounds. Design: This was a prospective comparative hospital-based study. Setting: Patients who had surgery for secondary peritonitis in Irrua Specialist Teaching Hospital were studied. Participants: Fifty patients aged 16 years and above who presented with secondary peritonitis. Intervention: Patients who met the inclusion criteria were randomized into two equal groups. Group A had a suction drain placed in the subcutaneous space after laparotomy while Group B did not. Main outcome measures: Development of incisional surgical site infection, wound dehiscence, and duration of post-operative hospital stay. Results: The incidence of incisional surgical site infection was significantly less in Group A (20%) than in Group B (68%). There was no case of wound dehiscence in Group A as against 3 (12%) in Group B. The difference was not statistically significant. The mean duration of hospital stay was significantly less with subcutaneous suction drain (8.96+2.81 Vs 14.04+8.05; p = 0.005). Conclusion: Subcutaneous suction drainage is beneficial in abdominal wall closure in cases of peritonitis as it significantly reduces the incidence of incisional surgical site infection and the duration of postoperative hospital stay. The reduction in surgical wound dehiscence observed in this study was, however, not statistically significant. Funding: None declared.


Subject(s)
Abdominal Wound Closure Techniques , Length of Stay , Peritonitis , Surgical Wound Dehiscence , Surgical Wound Infection , Humans , Male , Female , Surgical Wound Infection/prevention & control , Surgical Wound Infection/epidemiology , Middle Aged , Prospective Studies , Adult , Peritonitis/etiology , Surgical Wound Dehiscence/epidemiology , Surgical Wound Dehiscence/prevention & control , Surgical Wound Dehiscence/etiology , Abdominal Wound Closure Techniques/instrumentation , Aged , Sepsis/etiology , Sepsis/epidemiology , Drainage/instrumentation , Laparotomy , Suction/methods , Young Adult
2.
Virulence ; 15(1): 2367659, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38951957

ABSTRACT

Vancomycin-resistant Enterococcus faecium (E. faecium) infection is associated with higher mortality rates. Previous studies have emphasized the importance of innate immune cells and signalling pathways in clearing E. faecium, but a comprehensive analysis of host-pathogen interactions is lacking. Here, we investigated the interplay of host and E. faecium in a murine model of septic peritonitis. Following injection with a sublethal dose, we observed significantly increased murine sepsis score and histological score, decreased weight and bacterial burden, neutrophils and macrophages infiltration, and comprehensive activation of cytokine-mediated signalling pathway. In mice receiving a lethal dose, hypothermia significantly improved survival, reduced bacterial burden, cytokines, and CD86 expression of MHC-II+ recruited macrophages compared to the normothermia group. A mathematical model constructed by observational data from 80 animals, recapitulated the host-pathogen interplay, and further verified the benefits of hypothermia. These findings indicate that E. faecium triggers a severe activation of cytokine-mediated signalling pathway, and hypothermia can improve outcomes by reducing bacterial burden and inflammation.


Subject(s)
Cytokines , Disease Models, Animal , Enterococcus faecium , Gram-Positive Bacterial Infections , Host-Pathogen Interactions , Peritonitis , Sepsis , Vancomycin-Resistant Enterococci , Animals , Peritonitis/microbiology , Peritonitis/immunology , Mice , Gram-Positive Bacterial Infections/immunology , Gram-Positive Bacterial Infections/microbiology , Vancomycin-Resistant Enterococci/pathogenicity , Sepsis/microbiology , Sepsis/immunology , Cytokines/metabolism , Mice, Inbred C57BL , Macrophages/immunology , Macrophages/microbiology , Signal Transduction
3.
Eur J Gastroenterol Hepatol ; 36(8): 1022-1028, 2024 Aug 01.
Article in English | MEDLINE | ID: mdl-38973543

ABSTRACT

BACKGROUND: Vasodilatation and bacterial dislocation are the main contributors to the catastrophic events in patients with decompensated liver cirrhosis (DLC). AIM: The aim of this study was to evaluate the impacts of adding midodrine and rifaximin on morbidity, mortality, and quality of life in patients with DLC. METHODS: This interventional clinical study included 100 consecutively enrolled DLC patients randomized 1 : 1 into two groups. Group A received oral midodrine (5 mg/8 h) and rifaximin (550 mg/12 h) with standard diuretic therapy, while group B received only standard diuretic therapy. Clinical and laboratory data, including the McGill Quality of Life Questionnaire, were evaluated over a 3-month treatment period. RESULTS: In the study group, there was a significant reduction in Child-Pugh and Model for End-Stage Liver Disease scores, international normalized ratio, and mean arterial blood pressure at 2, 6, and 12 weeks (P < 0.05). Ascites, spontaneous bacterial peritonitis incidence, hematemesis, paracentesis need, and hepatic encephalopathy showed improvement after 12 weeks compared with the control group. McGill Quality of Life Questionnaire significantly improved after 6 and 12 weeks (P < 0.05). Survival rates demonstrated a noteworthy improvement (P = 0.014), substantiated by evidence in both univariate and multivariate regression analyses. CONCLUSION: Combined midodrine with rifaximin represents an endowment to patients with DLC with spectacular improvements in synthetic liver functions, along with improved quality of life, and survival.


Subject(s)
Liver Cirrhosis , Midodrine , Quality of Life , Rifamycins , Rifaximin , Humans , Rifaximin/therapeutic use , Female , Midodrine/therapeutic use , Midodrine/adverse effects , Male , Liver Cirrhosis/complications , Liver Cirrhosis/mortality , Liver Cirrhosis/drug therapy , Middle Aged , Rifamycins/therapeutic use , Rifamycins/adverse effects , Treatment Outcome , Drug Therapy, Combination , Adult , Ascites/etiology , Ascites/drug therapy , Ascites/mortality , Hepatic Encephalopathy/drug therapy , Hepatic Encephalopathy/etiology , Aged , Surveys and Questionnaires , Peritonitis/mortality , Time Factors
4.
Iran J Med Sci ; 49(6): 369-376, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38952643

ABSTRACT

Background: Spontaneous bacterial peritonitis (SBP) is a fatal complication of ascites fluid infection. The causes of SBP in children differ from those in adults, and these bacteria are frequently resistant to antibiotics. Therefore, this study investigated the clinical findings, bacterial etiology, and antimicrobial resistance in children with SBP. Methods: This study was conducted on all new pediatric ascites patients, who were admitted to the Department of Pediatric Gastroenterology, Namazi Hospital, affiliated with Shiraz University of Medical Sciences (Shiraz, Iran) from 2021 to 2022. Required data such as demographic information, and clinical information such as complete blood count (CBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Gram staining, blood culture by Automated Blood Culture System (BACTEC), and antibiogram of ascites fluids by disc diffusion method were all collected. Finally, the data were statistically analyzed using SPSS Software (version 26). Besides, the t test, Fisher's exact, Mann-Whitney, and Chi square tests were used for data analysis. In all tests, P≤0.05 was considered statistically significant. Results: The present study examined 62 children with ascites of which 18 (29%) had SBP. The median (IQR) age was 2.5 (8.1) years. Thirty-four (54.8%) of the participants were girls. Abdominal pain was the most common clinical manifestation in patients (54%), and there was a significant association between abdominal pain and SBP (P=0.02). In 12 positive ascites fluid cultures, coagulase-negative staphylococci had the highest frequency (25%), followed by Escherichia coli (16.7%). Third-generation cephalosporins had a 25% sensitivity in the total positive cultures. This sensitivity was 33.3% for Gram-negative cultures and 16.6% for Gram-positive cultures. Conclusion: Although third-generation cephalosporins are recommended as the primary antibiotic for the empirical treatment of SBP, the present study found high bacterial resistance. Finally, empirical therapy should be tailored to each region's bacterial resistance features.


Subject(s)
Anti-Bacterial Agents , Peritonitis , Tertiary Care Centers , Humans , Peritonitis/drug therapy , Peritonitis/microbiology , Child , Female , Male , Iran , Child, Preschool , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Tertiary Care Centers/statistics & numerical data , Tertiary Care Centers/organization & administration , Infant , Adolescent , Drug Resistance, Bacterial/drug effects , Ascites/drug therapy , Bacterial Infections/drug therapy , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/statistics & numerical data
5.
New Microbiol ; 47(2): 186-189, 2024 Jul.
Article in English | MEDLINE | ID: mdl-39023530

ABSTRACT

Stephanoascus ciferrii, a conditional pathogenic fungus prevalent in nature, is more frequently encountered in patients with compromised immunity. However, the literature rarely reports infections caused by Stephanoascus ciferrii in peritoneal dialysis patients. Here, we detail the case of a 66-year-old female suffering from renal failure who experienced catheter-related infection during peritoneal dialysis. Dialysate turbidity prompted the detection of Stephanoascus ciferrii in both peritoneal dialysate and tubes through microbiological cultures. Subsequent treatment involved antifungal drugs and a transition to hemodialysis, resulting in the disappearance of peritonitis symptoms and the patient's discharge. In recent years, fungal infections, particularly dialysis-related infections, are on the rise. This marks the first reported case of catheter-related peritonitis infection caused by Stephanoascus ciferrii. Compared to bacterial infections, fungal infections pose challenges due to limited drug options, significant side effects, and prolonged treatment durations. Hence, prompt pathogen diagnosis and drug sensitivity testing are crucial for effective clinical treatment. In essence, this scientific case report underscores the uncommon occurrence of catheter-related peritonitis attributed to Stephanoascus ciferrii in a peritoneal dialysis patient with renal failure, emphasizing the distinctive management challenges and underscoring the critical significance of prompt diagnosis and suitable intervention in such instances.


Subject(s)
Mycoses , Peritoneal Dialysis , Peritonitis , Humans , Female , Aged , Peritonitis/microbiology , Peritonitis/drug therapy , Peritonitis/etiology , Peritoneal Dialysis/adverse effects , Mycoses/microbiology , Mycoses/drug therapy , Antifungal Agents/therapeutic use , Catheter-Related Infections/microbiology , Catheter-Related Infections/drug therapy , Ascomycota/isolation & purification
6.
J Immunol Res ; 2024: 2899154, 2024.
Article in English | MEDLINE | ID: mdl-39021433

ABSTRACT

As another receptor for complement activation product C5a, C5aR2 has been paid much attention these years. Although controversial and complex, its specific signals or roles in modulating the classic receptor C5aR1 have been investigated and gradually revealed. The hypothesis of the heterodimer of C5aR1 and C5aR2 has also been suggested and observed under extremely high C5a concentrations. In this article, we tried to investigate whether C5aR2 would affect C5aR1 expression under normal or inflammatory conditions in WT and C5ar2 -/- mice of C57BL/6 background. We focused on the innate immune cells-neutrophils and macrophages. The mRNA levels of C5ar1 in normal kidney, liver, and the mRNA or protein levels of naïve-bone marrow and peripheral blood leukocytes and peritoneal Mφs were comparable between WT and C5ar2 -/- mice, indicating the technique of C5aR2 knockout did not affect the transcription of its neighboring gene C5aR1. However, the mean fluorescence intensity of surface C5aR1 on naïve circulating C5ar2 -/- neutrophils detected by FACS was reduced, which might be due to the reduced internalization of C5aR1 on C5ar2 -/- neutrophils. In the peritonitis model induced by i.p. injection of thioglycollate, more neutrophils were raised after 10 hr in C5ar2 -/- peritoneal cavity, indicating the antagonism of C5aR2 on C5aR1 signal in neutrophil chemotaxis. After 3 days of thioglycollate injection, the mainly infiltrating macrophages were comparable between WT and C5ar2 -/- mice, but the C5ar1 mRNA and surface or total C5aR1 protein expression were both reduced in C5ar2 -/- macrophages, combined with our previous study of reduced chemokines and cytokines expression in C5ar2 -/- peritoneal macrophages, indicating that C5aR2 in macrophages may cooperate with C5aR1 inflammatory signals. Our article found C5aR2 deficiency lessened C5aR1 distribution and expression in neutrophils and macrophages with different functions, indicating C5aR2 might function differently in different cells.


Subject(s)
Macrophages , Mice, Inbred C57BL , Mice, Knockout , Neutrophils , Peritonitis , Receptor, Anaphylatoxin C5a , Animals , Receptor, Anaphylatoxin C5a/metabolism , Receptor, Anaphylatoxin C5a/genetics , Neutrophils/immunology , Neutrophils/metabolism , Mice , Macrophages/immunology , Macrophages/metabolism , Peritonitis/immunology , Disease Models, Animal , Complement C5a/metabolism , Complement C5a/immunology , Immunity, Innate
7.
Ren Fail ; 46(2): 2368083, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38958248

ABSTRACT

OBJECTIVE: To identify the risk factors of refractory peritoneal dialysis related peritonitis (PDRP) and construct a nomogram to predict the occurrence of refractory PDRP. METHODS: Refractory peritonitis was defined as the peritonitis episode with persistently cloudy bags or persistent dialysis effluent leukocyte count >100 × 109/L after 5 days of appropriate antibiotic therapy. The study dataset was randomly divided into a 70% training set and a 30% validation set. Univariate logistic analysis, LASSO regression analysis, and random forest algorithms were utilized to identify the potential risk factors for refractory peritonitis. Independent risk factors identified using multivariate logistic analysis were used to construct a nomogram. The discriminative ability, calibrating ability, and clinical practicality of the nomogram were evaluated using the receiver operating characteristic curve, Hosmer-Lemeshow test, calibration curve, and decision curve analysis. RESULTS: A total of 294 peritonitis episodes in 178 patients treated with peritoneal dialysis (PD) were enrolled, of which 93 were refractory peritonitis. C-reactive protein, serum albumin, diabetes mellitus, PD duration, and type of causative organisms were independent risk factors for refractory peritonitis. The nomogram model exhibited excellent discrimination with an area under the curve (AUC) of 0.781 (95% CI: 0.716-0.847) in the training set and 0.741 (95% CI: 0.627-0.855) in the validation set. The Hosmer-Lemeshow test and calibration curve indicated satisfactory calibration ability of the predictive model. Decision curve analysis revealed that the nomogram model had good clinical utility in predicting refractory peritonitis. CONCLUSION: This nomogram can accurately predict refractory peritonitis in patients treated with PD.


Subject(s)
Nomograms , Peritoneal Dialysis , Peritonitis , Humans , Peritonitis/etiology , Peritonitis/diagnosis , Peritoneal Dialysis/adverse effects , Male , Female , Middle Aged , Risk Factors , Adult , Aged , ROC Curve , Retrospective Studies , Logistic Models , Anti-Bacterial Agents/therapeutic use , Kidney Failure, Chronic/therapy , Kidney Failure, Chronic/complications , C-Reactive Protein/analysis
8.
Ren Fail ; 46(2): 2376331, 2024 Dec.
Article in English | MEDLINE | ID: mdl-39011577

ABSTRACT

OBJECT: This study aims to conduct a systematic review and network meta-analysis to comprehensively evaluate the efficacy of various dressings in preventing exit-site infection (ESI) and peritonitis. METHODS: We searched PubMed, Embase, Web of Science, CINAHL Plus with Full Text (EBSCO), Sino Med, Wan Fang Data, China National Knowledge Infrastructure (CNKI) from 1 January 1999 to 10 July 2023. The language restrictions were Chinese and English. Randomized controlled trials, non-randomized controlled trials, and self-controlled trials were included in this study. We used ROB 2 tool to evaluate the quality of the included literature. Two authors independently extracted the data according to the Cochrane Handbook. A Frequentist network meta-analysis was performed using Stata17.0 according to PRISAMA with a random effects model. RESULTS: From 2092 potentially eligible studies, thirteen studies were selected for analysis, including nine randomized controlled studies, three quasi-experimental studies and one self-controlled trial. A total of 1229 patients were included to compare five types of exit site care dressings, named disinfection dressings, antibacterial dressings, non-antibacterial occlusive dressings, sterile gauze, and no-particular dressings. The outcome of prevention ESI is antibacterial dressings (SUCRA = 97.6) >non-antibacterial occlusive dressings (SUCRA = 68.3) >disinfection dressings (SUCRA = 50.6) >no-particular dressings (SUCRA = 23.9) >sterile gauze (SUCRA = 9.5). The antibacterial dressings were more effective than sterile gauze (OR = 0.13, 95%CI 0.04∼0.44), and no-particular dressing (OR = 0.18, 95%CI 0.07∼0.50) in preventing ESI; the non-antibacterial occlusive dressings were effective than sterile gauze (OR:0.30, 95%CI 0.16∼0.57). There is no statistical significance between no-particular dressings and other types of dressings in preventing the mature ESI. There is no statistical significance in the effectiveness of five types of dressings in preventing peritonitis. CONCLUSIONS: The no-particular dressings maybe more cost-effective for preventing mature ESI. None of the dressings was more effective than another in preventing peritonitis. Then, none of the different types of dressing is strongly recommended for preventing ESI or peritonitis.RegistrationCRD42022366756.


Subject(s)
Bandages , Network Meta-Analysis , Peritoneal Dialysis , Peritonitis , Humans , Peritonitis/prevention & control , Peritonitis/etiology , Peritonitis/microbiology , Peritoneal Dialysis/adverse effects , Catheter-Related Infections/prevention & control , Catheters, Indwelling/adverse effects , Catheters, Indwelling/microbiology
9.
Front Immunol ; 15: 1337384, 2024.
Article in English | MEDLINE | ID: mdl-38827745

ABSTRACT

Fibroblastic reticular cells (FRCs) are a subpopulation of stromal cells modulating the immune environments in health and disease. We have previously shown that activation of TLR9 signaling in FRC in fat-associated lymphoid clusters (FALC) regulate peritoneal immunity via suppressing immune cell recruitment and peritoneal resident macrophage (PRM) retention. However, FRCs are heterogeneous across tissues and organs. The functions of each FRC subset and the regulation of TLR9 in distinct FRC subsets are unknown. Here, we confirmed that specific deletion of TLR9 in FRC improved bacterial clearance and survival during peritoneal infection. Furthermore, using single-cell RNA sequencing, we found two subsets of FRCs (CD55hi and CD55lo) in the mesenteric FALC. The CD55hi FRCs were enriched in gene expression related to extracellular matrix formation. The CD55lo FRCs were enriched in gene expression related to immune response. Interestingly, we found that TLR9 is dominantly expressed in the CD55lo subset. Activation of TLR9 signaling suppressed proliferation, cytokine production, and retinoid metabolism in the CD55lo FRC, but not CD55hi FRC. Notably, we found that adoptive transfer of Tlr9 -/-CD55lo FRC from mesenteric FALC more effectively improved the survival during peritonitis compared with WT-FRC or Tlr9 -/-CD55hi FRC. Furthermore, we identified CD55hi and CD55lo subsets in human adipose tissue-derived FRC and confirmed the suppressive effect of TLR9 on the proliferation and cytokine production in the CD55lo subset. Therefore, inhibition of TLR9 in the CD55lo FRCs from adipose tissue could be a useful strategy to improve the therapeutic efficacy of FRC-based therapy for peritonitis.


Subject(s)
Fibroblasts , Peritonitis , Signal Transduction , Toll-Like Receptor 9 , Animals , Humans , Male , Mice , Disease Models, Animal , Fibroblasts/metabolism , Fibroblasts/immunology , Immunomodulation , Mice, Inbred C57BL , Mice, Knockout , Peritonitis/immunology , Peritonitis/metabolism , Toll-Like Receptor 9/metabolism , Toll-Like Receptor 9/genetics
10.
J Ethnopharmacol ; 333: 118496, 2024 Oct 28.
Article in English | MEDLINE | ID: mdl-38936643

ABSTRACT

ETHNOPHARMACOLOGY RELEVANCE: Schinus terebinthifolia Raddi (Anacardiaceae), known as Brazilian pepper tree, stands out as a medicinal plant widely used in traditional medicine. The leaves are popularly used as anti-inflammatory agent and to relieve inflammatory conditions such as bronchitis, ulcers, and wounds, for example. AIM OF THE STUDY: The present study evaluated the acute toxicity, genotoxicity, and anti-inflammatory activity of S. terebinthifolia leaf lectin (SteLL) in mice (Mus musculus). MATERIALS AND METHODS: In the acute toxicity assay, the animals were treated intraperitoneally (i.p.) or orally (per os) with a single dose of 100 mg/kg. Genotoxicity was assessed by the comet and micronucleus assays. Carrageenan-induced peritonitis and paw edema models were used to evaluate the anti-inflammatory effects of SteLL (1, 5 and 10 mg/kg, i.p.). RESULTS: No animal died and no signs of intoxication or histopathological damage were observed in the acute toxicity assay. Genotoxic effect was not detected. In peritonitis assay, SteLL reduced in 56-69% leukocyte migration to the peritoneal cavity; neutrophil count decreased by 25-32%, while mononuclear cell count increased by 67-74%. SteLL promoted a notable reduction of paw edema after 4 h (61.1-63.4%). Morphometric analysis showed that SteLL also decreased the thickness of epidermal edema (30.2-40.7%). Furthermore, SteLL decreased MPO activity, plasma leakage, NO release, and modulated cytokines in both peritoneal fluid and paw homogenate. CONCLUSION: SteLL did not induce acute toxicity or genotoxicity in mice and stands out as a promising candidate in the development of new phytopharmaceuticals with anti-inflammatory action.


Subject(s)
Anacardiaceae , Anti-Inflammatory Agents , Edema , Plant Extracts , Plant Leaves , Animals , Anacardiaceae/chemistry , Mice , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/isolation & purification , Male , Edema/drug therapy , Edema/chemically induced , Plant Extracts/pharmacology , Plant Lectins/pharmacology , Plant Lectins/isolation & purification , Toxicity Tests, Acute , Peritonitis/drug therapy , Peritonitis/chemically induced , Micronucleus Tests , Female , Carrageenan , Comet Assay , DNA Damage/drug effects , Dose-Response Relationship, Drug , Schinus
11.
Proc Natl Acad Sci U S A ; 121(27): e2402143121, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38923993

ABSTRACT

The non-neural cholinergic system plays a critical role in regulating immune equilibrium and tissue homeostasis. While the expression of choline acetyltransferase (ChAT), the enzyme catalyzing acetylcholine biosynthesis, has been well documented in lymphocytes, its role in the myeloid compartment is less understood. Here, we identify a significant population of macrophages (Mϕs) expressing ChAT and synthesizing acetylcholine in the resolution phase of acute peritonitis. Using Chat-GFP reporter mice, we observed marked upregulation of ChAT in monocyte-derived small peritoneal Mϕs (SmPMs) in response to Toll-like receptor agonists and bacterial infections. These SmPMs, phenotypically and transcriptionally distinct from tissue-resident large peritoneal macrophages, up-regulated ChAT expression through a MyD88-dependent pathway involving MAPK signaling. Notably, this process was attenuated by the TRIF-dependent TLR signaling pathway, and our tests with a range of neurotransmitters and cytokines failed to induce a similar response. Functionally, Chat deficiency in Mϕs led to significantly decreased peritoneal acetylcholine levels, reduced efferocytosis of apoptotic neutrophils, and a delayed resolution of peritonitis, which were reversible with exogenous ACh supplementation. Intriguingly, despite B lymphocytes being a notable ChAT-expressing population within the peritoneal cavity, Chat deletion in B cells did not significantly alter the resolution process. Collectively, these findings underscore the crucial role of Mϕ-derived acetylcholine in the resolution of inflammation and highlight the importance of the non-neuronal cholinergic system in immune regulation.


Subject(s)
Acetylcholine , Choline O-Acetyltransferase , Macrophages, Peritoneal , Peritonitis , Animals , Choline O-Acetyltransferase/metabolism , Choline O-Acetyltransferase/genetics , Peritonitis/immunology , Peritonitis/metabolism , Mice , Macrophages, Peritoneal/metabolism , Macrophages, Peritoneal/immunology , Acetylcholine/metabolism , Myeloid Differentiation Factor 88/metabolism , Myeloid Differentiation Factor 88/genetics , Mice, Inbred C57BL , Signal Transduction , Inflammation/metabolism , Inflammation/pathology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Toll-Like Receptors/metabolism , Phagocytosis , Macrophages/metabolism , Macrophages/immunology , Mice, Knockout
12.
BMJ Case Rep ; 17(6)2024 Jun 06.
Article in English | MEDLINE | ID: mdl-38844354

ABSTRACT

Enteric gram-negative bacteria-associated peritoneal dialysis (PD) peritonitis is common. These organisms are such as Escherichia coli, Klebsiella and Enterobacter species. Pantoea dispersa belongs to the order Enterobacterales, it has known benefits and a role in agricultural and environmental biotechnology. Pantoea dispersa, although still relatively rare, is being increasingly recognised to cause human infections. We are reporting a case of PD peritonitis caused by Pantoea dispersa in a kidney failure patient on continuous ambulatory peritoneal dialysis (CAPD). His peritonitis was treated well with intraperitoneal antibiotics and the patient can resume his CAPD therapy. The increasing reports of Pantoea dispersa-related human infections warrant concerns, both in immunocompromised and immunocompetent patients.


Subject(s)
Anti-Bacterial Agents , Catheter-Related Infections , Enterobacteriaceae Infections , Pantoea , Peritoneal Dialysis, Continuous Ambulatory , Peritonitis , Humans , Pantoea/isolation & purification , Male , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/microbiology , Peritonitis/drug therapy , Peritonitis/etiology , Peritonitis/diagnosis , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/drug therapy , Catheter-Related Infections/microbiology , Catheter-Related Infections/drug therapy , Catheter-Related Infections/diagnosis , Anti-Bacterial Agents/therapeutic use , Kidney Failure, Chronic/therapy , Kidney Failure, Chronic/complications , Middle Aged
13.
Cir Cir ; 92(3): 395-398, 2024.
Article in English | MEDLINE | ID: mdl-38862118

ABSTRACT

A rare condition, sclerosing encapsulating peritonitis, is characterized by a fibrotic membrane forming over the bowels, leading to intestinal obstruction. In this case of a 56-year-old male patient with a history of laparoscopic gastric bypass, a computed tomography scan showed findings indicative of the condition. Extensive adhesiolysis was performed, and biopsies confirmed the presence of fusiform cells (D2-40 positive on immunochemistry) resembling fibroblasts, within dense collagenous peritoneal tissue sheets, typical of sclerosing encapsulating peritonitis. The prevalence of this condition is uncertain, and diagnosis typically requires a peritoneal biopsy due to the nonspecific clinical presentation.


La peritonitis esclerosante encapsulada es una condición rara caracterizada por una membrana fibrótica que se genera sobre las asas intestinales causando cuadros de oclusión intestinal. Se presenta el caso de un paciente varón de 56 años con antecedente de derivación gastroyeyunal por laparoscopia que presenta oclusión intestinal. Se realizó tomografía computada que evidenció sitio de transición previo al sitio de anastomosis. Se realizó de anastomosis extensa y toma de biopsias. Histológicamente se observó engrosamiento de la membrana peritoneal, células fusiformes (D2-40 positivo en inmunohistoquímica) similares a fibroblastos con láminas de colágeno peritoneal denso. La peritonitis esclerosante encapsulada es una patología de prevalencia desconocida. El cuadro clínico es inespecífico y el diagnóstico definitivo es por patología con biopsia peritoneal.


Subject(s)
Gastric Bypass , Intestinal Obstruction , Peritoneal Fibrosis , Postoperative Complications , Humans , Male , Middle Aged , Gastric Bypass/adverse effects , Intestinal Obstruction/etiology , Intestinal Obstruction/surgery , Postoperative Complications/etiology , Peritoneal Fibrosis/etiology , Peritoneal Fibrosis/surgery , Peritoneal Fibrosis/complications , Peritoneal Fibrosis/diagnostic imaging , Peritonitis/etiology , Syndrome , Tissue Adhesions/complications , Tomography, X-Ray Computed , Intestine, Small
14.
Cells ; 13(11)2024 May 26.
Article in English | MEDLINE | ID: mdl-38891050

ABSTRACT

Acute inflammation is a rapid and dynamic process involving the recruitment and activation of multiple cell types in a coordinated and precise manner. Here, we investigate the origin and transcriptional reprogramming of monocytes using a model of acute inflammation, zymosan-induced peritonitis. Monocyte trafficking and adoptive transfer experiments confirmed that monocytes undergo rapid phenotypic change as they exit the blood and give rise to monocyte-derived macrophages that persist during the resolution of inflammation. Single-cell transcriptomics revealed significant heterogeneity within the surface marker-defined CD11b+Ly6G-Ly6Chi monocyte populations within the blood and at the site of inflammation. We show that two major transcriptional reprogramming events occur during the initial six hours of Ly6Chi monocyte mobilisation, one in the blood priming monocytes for migration and a second at the site of inflammation. Pathway analysis revealed an important role for oxidative phosphorylation (OxPhos) during both these reprogramming events. Experimentally, we demonstrate that OxPhos via the intact mitochondrial electron transport chain is essential for murine and human monocyte chemotaxis. Moreover, OxPhos is needed for monocyte-to-macrophage differentiation and macrophage M(IL-4) polarisation. These new findings from transcriptional profiling open up the possibility that shifting monocyte metabolic capacity towards OxPhos could facilitate enhanced macrophage M2-like polarisation to aid inflammation resolution and tissue repair.


Subject(s)
Antigens, Ly , Cell Differentiation , Inflammation , Macrophages , Monocytes , Oxidative Phosphorylation , Monocytes/metabolism , Animals , Macrophages/metabolism , Inflammation/pathology , Inflammation/metabolism , Humans , Mice , Antigens, Ly/metabolism , Chemotaxis , Mice, Inbred C57BL , Peritonitis/metabolism , Peritonitis/chemically induced , Peritonitis/pathology , Zymosan/pharmacology , Mitochondria/metabolism , Cellular Reprogramming
15.
Khirurgiia (Mosk) ; (6): 88-93, 2024.
Article in Russian | MEDLINE | ID: mdl-38888024

ABSTRACT

Traditional surgical treatment of widespread purulent peritonitis has some disadvantages that emphasizes the need for new approaches to postoperative care. The authors present successful treatment of diffuse purulent peritonitis using a combination of 'open abdomen' technology and VAC therapy. This approach reduces abdominal inflammation and intra-abdominal pressure. Combination of 'open abdomen' technology and VAC therapy provides effective control of inflammation and stabilization of patients with purulent peritonitis.


Subject(s)
Intra-Abdominal Hypertension , Negative-Pressure Wound Therapy , Peritonitis , Humans , Peritonitis/etiology , Peritonitis/surgery , Peritonitis/diagnosis , Intra-Abdominal Hypertension/etiology , Intra-Abdominal Hypertension/diagnosis , Intra-Abdominal Hypertension/surgery , Treatment Outcome , Negative-Pressure Wound Therapy/methods , Male , Female , Middle Aged , Severity of Illness Index
16.
Mycopathologia ; 189(4): 57, 2024 Jun 15.
Article in English | MEDLINE | ID: mdl-38878212

ABSTRACT

A 67 year-old male was admitted in the ICU because of multi-organ failure due to sepsis secondary to Fournier's gangrene. He had sustained radical prostatectomy in the last 48 hours. Peritoneal fluid and fatty tissue biopsies grew Aspergillus Fumigatus without concomitant pulmonary involvement. Postoperative acquisition via exogenous and endogenous routes is discussed, as this nosocomial entity is very rarely reported apart from peritoneal dialysis, especially in non-immunosuppressed patients.


Subject(s)
Aspergillosis , Aspergillus fumigatus , Peritonitis , Postoperative Complications , Humans , Male , Aspergillus fumigatus/isolation & purification , Aged , Peritonitis/microbiology , Peritonitis/pathology , Peritonitis/etiology , Aspergillosis/microbiology , Aspergillosis/diagnosis , Aspergillosis/pathology , Aspergillosis/etiology , Postoperative Complications/microbiology , Postoperative Complications/etiology , Prostatectomy/adverse effects
17.
Front Cell Infect Microbiol ; 14: 1373036, 2024.
Article in English | MEDLINE | ID: mdl-38873095

ABSTRACT

Serratia marcescens, as a Gram-negative opportunistic pathogen, is a rare cause of peritonitis and has worse clinical outcomes than Gram-positive peritonitis. In this case report, we describe a case of Serratia marcescens associated peritonitis that was successfully cured without catheter removal. A 40-year-old male patient with peritoneal dialysis who worked in the catering industry was admitted to the hospital for 16 hours after the discovery of cloudy peritoneal dialysate and abdominal pain. Ceftazidime and cefazolin sodium were immediately given intravenously as an empirical antibiotic regimen. After detecting Serratia marcescens in the peritoneal diasate culture, the treatment was switched to ceftazidime and levofloxacin. The routine examination of peritoneal dialysate showed a significant decrease in white blood cells, the peritoneal dialysate became clear, and the peritoneal dialysis catheter was retained. The patient was treated for 2 weeks and treated with oral antibiotics for 1 week. It is necessary to further strengthen the hygiene of work environment to prevent Serratia marcescens infection in peritoneal dialysis patients. We recommend that patients with Serratia marcescens associated peritonitis should be treated with a combination of antibiotics as early as possible empirically, and at the same time, the peritoneal dialysis fluid culture should be improved, and the antibiotic regimen should be timely adjusted according to the drug sensitivity results. For patients with clinical symptoms for more than 3 days, considering the strong virulence of Serratia marcescens, whether to use meropenem directly or not can provide a reference for clinical decision-making. Further clinical studies are needed to achieve more precise anti-infective treatment.


Subject(s)
Anti-Bacterial Agents , Peritoneal Dialysis , Peritonitis , Serratia Infections , Serratia marcescens , Humans , Serratia marcescens/isolation & purification , Male , Peritonitis/microbiology , Peritonitis/drug therapy , Adult , Serratia Infections/microbiology , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/administration & dosage , Peritoneal Dialysis/adverse effects , Treatment Outcome , Device Removal , Levofloxacin/therapeutic use , Ceftazidime/therapeutic use , Ceftazidime/administration & dosage , Cefazolin/therapeutic use
18.
BMC Surg ; 24(1): 192, 2024 Jun 20.
Article in English | MEDLINE | ID: mdl-38902655

ABSTRACT

BACKGROUND: Temporary abdominal closure (TAC) techniques are essential in managing open abdomen cases, particularly in damage control surgery. Skin-only closure (SC) and Bogota bag closure (BBC) are commonly used methods for TAC, but their comparative effectiveness in achieving primary fascial closure (PFC) remains unclear. The objective of this study was to evaluate the rates of PFC between patients undergoing SC and BBC techniques for TAC in peritonitis or abdominal trauma cases at a tertiary care hospital. METHODS: A retrospective cross-sectional study was conducted at the Surgical A Unit of Hayatabad Medical Complex, Peshawar, from January 2022 to July 2023. Approval was obtained from the institutional review board, and patient consent was secured for data use. Patients undergoing temporary abdominal closure using either skin-only or Bogota bag techniques were included. Exclusions comprised patients younger than 15 or older than 75 years, those with multiple abdominal wall incisions, and those with prior abdominal surgeries. Data analysis utilized SPSS version 25. The study aimed to assess outcomes following damage control surgery, focusing on primary fascial closure rates and associated factors. Closure techniques (skin-only and Bogota bag) were chosen based on institutional protocols and clinical context. Indications for damage control surgery (DCS) included traumatic and non-traumatic emergencies. Intra-abdominal pressure (IAP) was measured using standardized methods. Patients were divided into SC and BBC groups for comparison. Criteria for reoperation and primary fascial closure were established, with timing and technique determined based on clinical assessment and multidisciplinary team collaboration. The decision to leave patients open during the index operation followed damage control surgery principles. RESULTS: A total of 193 patients were included in this study, with 59.0% undergoing skin-only closure (SC) and 41.0% receiving Bogota bag closure (BBC). Patients exhibited similar demographic characteristics across cohorts, with a majority being male (73.1%) and experiencing acute abdomen of non-traumatic origin (58.0%). Among the reasons for leaving the abdomen open, severe intra-abdominal sepsis affected 51.3% of patients, while 42.0% experienced hemodynamic instability. Patients who received SC had significantly higher rates of primary fascial closure (PFC) compared to BBC (85.1% vs. 65.8%, p = 0.04), with lower rates of fascial dehiscence (1.7% vs. 7.6%, p = 0.052) and wound infections (p = 0.010). Multivariate regression analysis showed SC was associated with a higher likelihood of achieving PFC compared to BBC (adjusted OR = 1.7, 95% CI: 1.3-3.8, p < 0.05). CONCLUSION: In patients with peritonitis or abdominal trauma, SC demonstrated higher rates of PFC compared to BBC for TAC in our study population. However, further studies are warranted to validate these results and explore the long-term outcomes associated with different TAC techniques.


Subject(s)
Abdominal Injuries , Abdominal Wound Closure Techniques , Fasciotomy , Humans , Retrospective Studies , Male , Female , Cross-Sectional Studies , Adult , Middle Aged , Abdominal Injuries/surgery , Fasciotomy/methods , Peritonitis/surgery , Peritonitis/etiology
19.
Am J Case Rep ; 25: e943953, 2024 Jun 04.
Article in English | MEDLINE | ID: mdl-38831580

ABSTRACT

BACKGROUND Peritoneal dialysis (PD) serves as a critical renal replacement therapy for individuals with end-stage renal disease (ESRD), leveraging the peritoneum for fluid and substance exchange. Despite its effectiveness, PD is marred by complications such as peritonitis, which significantly impacts patient outcomes. The novelty of our report lies in the presentation of a rare case of PD-associated peritonitis caused by 2 unusual pathogens, emphasizing the importance of rigorous infection control measures. CASE REPORT We report on an 80-year-old African-American female patient with ESRD undergoing PD, who was admitted twice within 8 months for non-recurring episodes of peritonitis. These episodes were attributed to the rare pathogens Achromobacter denitrificans/xylosoxidans and Carbapenem-resistant Acinetobacter baumannii. Despite presenting with similar symptoms during each episode, such as abdominal pain and turbid dialysis effluent, the presence of these uncommon bacteria highlights the intricate challenges in managing infections associated with PD. The treatment strategy encompassed targeted antibiotic therapy, determined through susceptibility testing. Notably, the decision to remove the PD catheter followed extensive patient education, ensuring the patient comprehended the rationale behind this approach. This crucial step, along with the subsequent shift to hemodialysis, was pivotal in resolving the infection, illustrating the importance of patient involvement in the management of complex PD-related infections. CONCLUSIONS This case underscores the complexities of managing PD-associated peritonitis, particularly with uncommon and resistant bacteria. It emphasizes the importance of rigorous infection control measures, the need to consider atypical pathogens, and the critical role of patient involvement in treatment decisions. Our insights advocate for a more informed approach to handling such infections, aiming to reduce morbidity and improve patient outcomes. The examination of the literature on recurrent peritonitis and treatment strategies provides key perspectives for navigating these challenging cases effectively.


Subject(s)
Kidney Failure, Chronic , Peritoneal Dialysis , Peritonitis , Humans , Peritonitis/microbiology , Peritonitis/etiology , Female , Aged, 80 and over , Peritoneal Dialysis/adverse effects , Kidney Failure, Chronic/therapy , Kidney Failure, Chronic/complications , Acinetobacter baumannii , Achromobacter denitrificans , Anti-Bacterial Agents/therapeutic use , Gram-Negative Bacterial Infections/diagnosis , Acinetobacter Infections/drug therapy , Practice Guidelines as Topic
20.
World J Emerg Surg ; 19(1): 21, 2024 06 05.
Article in English | MEDLINE | ID: mdl-38840189

ABSTRACT

BACKGROUND: The high rate of stoma placement during emergency laparotomy for secondary peritonitis is a paradigm in need of change in the current fast-track surgical setting. Despite growing evidence for the feasibility of primary bowel reconstruction in a peritonitic environment, little data substantiate a surgeons' choice between a stoma and an anastomosis. The aim of this retrospective analysis is to identify pre- and intraoperative parameters that predict the leakage risk for enteric sutures placed during source control surgery (SCS) for secondary peritonitis. METHODS: Between January 2014 and December 2020, 497 patients underwent SCS for secondary peritonitis, of whom 187 received a primary reconstruction of the lower gastro-intestinal tract without a diverting stoma. In 47 (25.1%) patients postoperative leakage of the enteric sutures was directly confirmed during revision surgery or by computed tomography. Quantifiable predictors of intestinal suture outcome were detected by multivariate analysis. RESULTS: Length of intensive care, in-hospital mortality and failure of release to the initial home environment were significantly higher in patients with enteric suture leakage following SCS compared to patients with intact anastomoses (p < 0.0001, p = 0.0026 and p =0.0009, respectively). Reduced serum choline esterase (sCHE) levels and a high extent of peritonitis were identified as independent risk factors for insufficiency of enteric sutures placed during emergency laparotomy. CONCLUSIONS: A preoperative sCHE < 4.5 kU/L and generalized fecal peritonitis associate with a significantly higher incidence of enteric suture insufficiency after primary reconstruction of the lower gastro-intestinal tract in a peritonitic abdomen. These parameters may guide surgeons when choosing the optimal surgical procedure in the emergency setting.


Subject(s)
Feces , Peritonitis , Humans , Female , Male , Retrospective Studies , Peritonitis/surgery , Middle Aged , Aged , Sutures , Anastomotic Leak , Postoperative Complications , Risk Factors , Biomarkers/blood , Laparotomy/methods , Laparotomy/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...